🇺🇸 FDA
Patent

US 10421805

Anti-hepatitis C antibodies and antigen binding fragments thereof

granted A61KA61K2039/505A61K39/00

Quick answer

US patent 10421805 (Anti-hepatitis C antibodies and antigen binding fragments thereof) held by United Kingdom Research and Innovation expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Kingdom Research and Innovation
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K39/00, A61K39/42, A61P